Foradil
(Formoterol)ApprovedSmall molecule
ViatrisFormoterol is used to help people with asthma and COPD breathe easier by relaxing the muscles around the airways in the lungs. It is a long-acting medication that keeps airways open for 12 hours or more.[2] Foradil is currently approved and in use across 14 indications[4].[1]
Foradil is one of 350 small molecule programs targeting Cardiovascular Disease. It is currently in Approved.
14
Indications
69
Total Trials
1
Active Trials
349
Competitors
3
FDA Applications
NDA/BLA/ANDA regulatory filings
Pipeline
Status by Indication[4][1]
Indication
Showing 10 of 13 indications
Competition
Competitive Landscape
317 competitors in COVID-19
#DrugCompanyPhaseTrials
1Foradil
ViatrisApproved
Stivarga
BayerPreclinical
Aimovig
AmgenPreclinical
Calciferol
Jazz PharmaceuticalsPreclinical
Activella
Eli LillyPreclinical
Angiomax
BBaxter Healthcare Corporation
Preclinical
Nitrostat
VViatris Specialty LLC
Preclinical
Low-Molecular-Weight Heparin
Daiichi SankyoPreclinical
Achromycin V
WWyeth-Lederle Vaccines
Preclinical
Glucocorticoid
AbbViePreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Chronic Obstructive Pulmonary Disease18 trials
Show 15 more trials
Asthma13 trials
Show 10 more trials
The Effects of Different Long-acting Bronchodilator Medications on Asthma Patients With Different Genetic Variations
Terminated·—·N/A·NCT00706446·255 enrolled
Polymorphism of beta2-adrenoceptor and Regular Use of Formoterol in Asthma
Completed·—··NCT01786616·30 enrolled
Efficacy4 trials
COPD4 trials
21 more indications
Treatment2 trials
PMD1 trial
Resistance1 trial
Effectiveness1 trial
Obstructive Pulmonary Disease1 trial
Single Dose1 trial
Glycopyrrolate1 trial
Type 1 Diabetes1 trial
Children1 trial
Monotherapy1 trial
Acute Lymphoblastic Leukemia1 trial
Sts1 trial
Blacks and Exacerbations on Long Acting Beta Agonists (LABA) vs. Tiotropium (BELT)
Completed·—·Phase 3·NCT01290874·1,070 enrolled
Unspecified6 trials
Show 3 more trials
Methacholine, Long-acting M-cholinolytic and beta2-agonist on the Activity of Beta-receptors in Healthy Volunteers
Unknown status·—·N/A·NCT04137029·20 enrolled
Rapid Onset Action of Salbutamol Versus Formoterol
Unknown status·—·Phase 4·NCT00900874·78 enrolled
Regulatory
FDA Approval Timeline[5]
Feb 16, 2001
FORADIL
NDA NDA020831
Dec 15, 2006
FORADIL CERTIHALER
NDA NDA021592
May 11, 2007
PERFOROMIST
NDA NDA022007
Sources
References
- [1]
- [2]MedlinePlus Drug Information — Foradil drug information. U.S. National Library of Medicine, National Institutes of Health.
- [3]
- [4]Open Targets Platform — Drug–disease associations for Formoterol. EMBL-EBI & Wellcome Sanger Institute.
- [5]
- [6]